Overview

Pharmacokinetics Ertapenem Burns

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study will examine the pharmacokinetics of ertapenem in ventilated badly (> 30% SCT) burn patients.
Phase:
Phase 4
Details
Lead Sponsor:
Nantes University Hospital
Treatments:
Ertapenem